cocktail – Lab DB

New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component

Lana Keisha Apr 15, 2026 0

QUAD is marketed by MEDVi as a sublingual, four-drug cocktail for erectile dysfunction, combining three well-known PDE5 inhibitors—sildenafil, tadalafil, and…

New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component

New York Times-lauded Medvi is marketing QUAD, a four-drug ED cocktail with a Parkinson’s drug component

YOU MAY HAVE MISSED

Can the heart heal itself? New study says it can

Groundbreaking Nanodisc Platform Unveils Unprecedented Insights into Viral Protein-Antibody Interactions, Promising Accelerated Vaccine Development

Eli Lilly is now pharma’s top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn’t celebrating

UC Berkeley Researchers Uncover Neural Circuit Linking Deep Sleep to Growth Hormone Release and Metabolic Health